About this trial
This study aims to compare the analgesic efficacy of surgeon-performed intraoperative adductor canal block (ACB) and ultrasound-guided anesthesiologist-performed ACB in patients undergoing bilateral total knee arthroplasty (TKA). In a prospective, randomized paired design, each patient will receive surgeon-performed ACB on one knee and anesthesiologist-performed ACB on the contralateral knee.
The primary outcome is postoperative pain measured using the Numeric Rating Scale (NRS), and the study is designed to evaluate the non-inferiority of surgeon-performed ACB. Secondary outcomes include opioid consumption, time to first ambulation, length of hospital stay, postoperative complications, and patient-reported outcome measures (PROMs).
Additionally, postoperative ultrasound evaluation will be performed to assess the distribution pattern of local anesthetic within the adductor canal, including cross-sectional area and longitudinal spread. This study is expected to provide evidence regarding the clinical effectiveness and technical accuracy of surgeon-performed ACB in comparison with the conventional ultrasound-guided technique.
Eligibility criteria
Qualifiers
Adult patients aged 19 years or older
Patients scheduled for bilateral total knee arthroplasty
Patients who provide written informed consent
Disqualifiers
Refusal to participate or inability to provide informed consent
Neurological or psychiatric conditions affecting cooperation (e.g., dementia, delirium)
Pre-existing neurological or anatomical abnormalities of the lower extremities
Chronic opioid use or opioid dependence
Trial design
Treatments tested in this trial
- Surgeon-Performed Adductor Canal Block
- Ultrasound-Guided Adductor Canal Block